The pharmacokinetics of lisuride hydrogen maleate in rat, rabbit and rhesus monkey.

Abstract:

:The pharmacokinetics of lisuride hydrogen maleate (LHM) were investigated in rat, rabbit and rhesus monkey. Experiments were designed to meet not only the requirements of drug registration but also to serve other preclinical disciplines (toxicology, pharmacology). LHM is absorbed almost completely at a dose level of 100-250 micrograms/kg. During absorption and first liver passage (FPE) LHM is metabolized. The FPE was highest in the rhesus monkey and lowest in the rat. Calculated on bioavailability during chronic tolerance studies, in the highest dose group rats were burdened with 180-fold and rhesus monkeys with 70-fold the highest human dose (parkinsonism). Total clearance values indicated the presence of extrahepatic metabolism in all animal species. Terminal half-lives of unchanged drug in plasma were in the range of a few hours. Therefore, no accumulation of unchanged drug was expected to occur following daily repeated administration in the animal species investigated. Elimination of 14C-radioactivity proceeded mainly via the liver in rat and rabbit. The rhesus monkey excreted most of the dose administered in the urine. Enterohepatic circulation of 14C-material was demonstrated in the rat. In the rat but not in the other two species a small part of the dose (about 2%) accumulated in blood cells in the form of metabolites. Unchanged lisuride is able to cross membranes very rapidly, this was shown in distribution studies (whole-body autoradiography of rat, direct measurements in rat and rabbit). Transfer of lisuride into fetuses and brain is governed by its concentration in plasma. Drug level decrease in fetuses and brain was shown to somewhat slower than in plasma. Detailed evaluation of the distribution pattern in the brain of rat and rabbit showed a high affinity of lisuride for its preferential target tissue, the pituitary.

authors

Humpel M,Toda T,Oshino N,Pommerenke G

doi

10.1007/BF03189490

subject

Has Abstract

pub_date

1981-01-01 00:00:00

pages

207-19

issue

3

eissn

0378-7966

issn

2107-0180

journal_volume

6

pub_type

杂志文章
  • A comparative "in vitro" study of permeability with different synthetic and biological membranes.

    abstract::Permeability coefficients of seven compounds belonging to a true homologous series (4-alkylanilines) through several different synthetic and biological membranes were assayed in a two-chamber diffusion cell. Permeability-lipophilicity relationships for the experimental data were established and compared in order to as...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:

    authors: Díez-Sales O,Guzmán D,Cano D,Martín A,Sánchez E,Herráez M

    更新日期:1991-01-01 00:00:00

  • Phenobarbital-digitoxin interaction in the guinea pig liver.

    abstract::The influence of phenobarbital pretreatment on liver concentration of digitoxin and its metabolites was studied in guinea-pigs after i.p. administration of the cardiac glycoside. During the first hour an increase in liver uptake was observed in pretreated animals. The differences detected in the hepatic subcellular di...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03189562

    authors: Carvalhas ML,Figueira MA,Maya MR

    更新日期:1982-01-01 00:00:00

  • Evaluation of Strategies for the Assessment of Drug-Drug Interactions Involving Cytochrome P450 Enzymes.

    abstract:BACKGROUND AND OBJECTIVES:Drug-drug interactions (DDIs) can occur when one drug alters the metabolism of another drug. Drug metabolism mediated by cytochrome P450 enzymes (CYPs) is responsible for the majority of metabolism of known drugs and inhibition of CYP enzymes is a well-known cause of DDIs. In the current study...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/s13318-018-0485-7

    authors: Reinen J,Smit M,Wenker M

    更新日期:2018-12-01 00:00:00

  • In vivo metabolism of the anti-inflammatory agent 2-(5-ethylpyridin-2-yl)benzimidazole.

    abstract::The metabolic fate of anti-inflammatory agent 2-(5-ethylpyridin-2-yl)benzimidazole (KB-1043) was studied in rats after oral administration. An average of 12.2 +/- 1.5% of the dose was excreted in the urine in the course of 0-48 h; 56.7 +/- 2.6% with feces. Two metabolites were also detected in the urine and isolated b...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03190109

    authors: Caputo O,Grosa G,Ceruti M,Viola F,Rocco F

    更新日期:1989-10-01 00:00:00

  • Assessment of Drug-Drug Interaction Potential Between Atorvastatin and LCZ696, A Novel Angiotensin Receptor Neprilysin Inhibitor, in Healthy Chinese Male Subjects.

    abstract:BACKGROUND AND OBJECTIVE:LCZ696 (sacubitril/valsartan), a novel angiotensin receptor neprilysin inhibitor has been recently approved for the treatment of patients with heart failure (HF) and reduced ejection fraction. As several HF patients are likely to use statins as co-medications, the potential for a pharmacokineti...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 临床试验,杂志文章

    doi:10.1007/s13318-016-0349-y

    authors: Ayalasomayajula S,Pan W,Han Y,Yang F,Langenickel T,Pal P,Zhou W,Yuan Y,Rajman I,Sunkara G

    更新日期:2017-04-01 00:00:00

  • Gender difference in ifosfamide metabolism by human liver microsomes.

    abstract::Pharmacokinetic gender-dependent differences in cytochrome P450-mediated drug metabolism, especially CYP3A4, and their clinical implications are increasingly apparent. CYP3A4 seems to be the most important CYP isoform in both bioactivation and N-dechloroethylation of the alkylating prodrug ifosfamide, but informations...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03190396

    authors: Schmidt R,Baumann F,Hanschmann H,Geissler F,Preiss R

    更新日期:2001-07-01 00:00:00

  • One-compartmental biometric blood loss calculation after cesarean section.

    abstract::Blood loss during cesarean section was calculated based on post-operative decrement of hemoglobin (Hb) and hematocrit (Hct) level. The model used for pregnant women was previously validated for non-pregnant women who underwent gynecological surgery. 1,068 pregnant women who underwent cesarean section and 517 women who...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/s13318-011-0042-0

    authors: Milosevic N,Popovic J,Grujic Z,Rapaic M

    更新日期:2011-09-01 00:00:00

  • Prediction of the pharmacokinetics and tissue distribution of levofloxacin in humans based on an extrapolated PBPK model.

    abstract::This study developed a physiologically based pharmacokinetic (PBPK) model in intraabdominally infected rats and extrapolated it to humans to predict the levofloxacin pharmacokinetics and penetration into tissues. Twelve male rats with intraabdominal infections induced by Escherichia coli received a single dose of 50 m...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/s13318-015-0271-8

    authors: Zhu L,Zhang Y,Yang J,Wang Y,Zhang J,Zhao Y,Dong W

    更新日期:2016-08-01 00:00:00

  • Influence of hepatic impairment on the pharmacokinetics of the dopamine agonist rotigotine.

    abstract::The transdermally applied dopamine receptor agonist rotigotine is extensively metabolized in the liver. An open-label, parallel-group study was conducted to evaluate the effects of moderate hepatic impairment on the pharmacokinetics, safety and tolerability of rotigotine. Eight subjects with normal hepatic function an...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章,多中心研究

    doi:10.1007/s13318-013-0153-x

    authors: Cawello W,Fichtner A,Boekens H,Braun M

    更新日期:2014-09-01 00:00:00

  • Differences in Intestinal Metabolism of Ginseng Between Normal and Immunosuppressed Rats.

    abstract:BACKGROUND AND OBJECTIVE:Ginseng is usually consumed as a dietary supplement for health care in the normal state or prescribed as a herbal medicine in pathologic conditions. Although metabolic studies of ginseng are commonly performed on healthy organisms, the metabolic characteristics in pathologic organisms remain un...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/s13318-020-00645-1

    authors: Zhu JH,Xu JD,Zhou SS,Zhang XY,Zhou J,Kong M,Mao Q,Zhu H,Li SL

    更新日期:2021-01-01 00:00:00

  • Solid-phase extraction of piribedil and its metabolites from plasma and urine without and after deconjugation, by high performance liquid chromatography.

    abstract::A new high performance liquid chromatographic procedure has been developed for the simultaneous quantification of piribedil (PD) and its three main basic metabolites in rat plasma and urine, without and after hydrolysis. The procedure relies on isolation of the compounds from plasma and urine constituents using the Se...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03190147

    authors: Sarati S,Caccia S

    更新日期:1992-07-01 00:00:00

  • A further study of the pharmacokinetics of gitoxin in rabbit isolated liver: clearance of 3H-gitoxin.

    abstract::Hepatic clearance of 3H-gitoxin was studied in the rabbit using an isolated perfused liver technique with an emulsion of a perfluorocarbon. The liposoluble material in the perfusion medium was extracted with dichloromethane, and gitoxin was assayed in the extract by high performance liquid chromatography. Pharmacokine...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03189704

    authors: Pellegrin PL,Lesne M

    更新日期:1985-04-01 00:00:00

  • Pharmacokinetics, hepatic biotransformation and biliary and urinary excretion of bromosulfophthalein (BSP) in an experimental liver disease mimicking biliary cirrhosis.

    abstract::We studied the hepatic handling of bromosulfophthalein in healthy rabbits with hepatic coccidiosis 28 days after an experimental infection with sporulated oocysts of Eimeria stiedai, an experimental model of liver disease histopathologically resembling primary biliary cirrhosis in man. A pharmacokinetic study of the r...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03190121

    authors: Esteller A,Torres MD,Gomez-Bautista M,Mariño EL,Fernandez-Lastra C,Jimenez R

    更新日期:1990-01-01 00:00:00

  • The pharmacokinetics of ceftriaxone based on population pharmacokinetics and the prediction of efficacy in Japanese adults.

    abstract:OBJECTIVE:By using a population pharmacokinetic analysis method, we predicted the efficacy of Ceftriaxone (CTRX) based on the pharmacokinetics of CTRX in Japanese adults and the sensitivity of infective organisms to CTRX in 2004. In addition, we clarified the difference in efficacy between once-a-day administration and...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03191159

    authors: Iida S,Kinoshita H,Kawanishi T,Hayashi M

    更新日期:2009-04-01 00:00:00

  • On the Molecular Basis Underlying the Metabolism of Tapentadol Through Sulfation.

    abstract:BACKGROUND AND OBJECTIVES:Previous studies reported that tapentadol-sulfate represented one of the major metabolites of tapentadol excreted in urine. The current study aimed to identify the human cytosolic sulfotransferases (SULTs) that is(are) capable of sulfating tapentadol and to examine whether human cells and huma...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/s13318-016-0392-8

    authors: Bairam AF,Rasool MI,Kurogi K,Liu MC

    更新日期:2017-10-01 00:00:00

  • Evaluation of hepatic dysfunction in endotoxin pretreated rats using tolbutamide as a marker.

    abstract::The pharmacokinetics of tolbutamide (TB) have been studied in endotoxin pretreated rats with the aim of evaluating TB as a marker for endotoxin effects. Endotoxin dose of 10 mg/kg resulted in a 50% rate of mortality. TB was i.v. administered 24 h. after endotoxin dosing. Clearance (Cl) decreased by approximately 2/3 o...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03190205

    authors: Kaka JS,al-Khamis K,Tanira MO

    更新日期:1990-07-01 00:00:00

  • Bioequivalency evaluation by comparison of in vitro dissolution and in vivo absorption using reference equations.

    abstract::Using in vitro dissolution and in vivo absorption of different generics or batches for an appropriate drug and dosage form, a reference equation of form: ka = a+bkd+dkd2 can be proposed. In the case of availability of standardised in vitro-in vivo data for a specific drug, a Level A a correlation of this type containi...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03188930

    authors: Kayali A

    更新日期:1994-07-01 00:00:00

  • Method of variability optimization in pharmacokinetic data analysis.

    abstract::For many drugs administered per os, high variability in the concentration-time (C-T) values from first sampling to the phase of distribution may cause difficulty in pharmacokinetic analysis. Therefore, the aim of this study was to propose a method of transformation of C-T data, which would allow significantly reducing...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/s13318-013-0145-x

    authors: Grabowski T,Jaroszewski JJ,Piotrowski W,Sasinowska-Motyl M

    更新日期:2014-06-01 00:00:00

  • Fate and disposition of bromocriptine in animals and man. I: structure elucidation of the metabolites.

    abstract::A total of 16 metabolites of bromocriptine could be isolated from rat bile and incubates of rat liver cell preparations using [6-methyl-14C]bromocriptine as substrate. Separation and purification was achieved by reversed-phase liquid chromatography and preparative thin-layer chromatography in conjunction with radioact...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03189631

    authors: Maurer G,Schreier E,Delaborde S,Loosli HR,Nufer R,Shukla AP

    更新日期:1982-10-01 00:00:00

  • Disposition of amiodarone in rats after single and multiple intra-peritoneal doses.

    abstract::The pharmacokinetics of amiodarone was studied after single and multiple dosing in two groups of male Wistar and Albino rats. The first group (40 rats) received a single intraperitoneal (i.p.) dose of amiodarone (100 mg/kg) and 4 rats sacrificed 1, 2, 4, 6, 12, 18, 24, 36, 48 and 72 hours post dosing. The second group...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03192314

    authors: Najjar TA

    更新日期:2000-07-01 00:00:00

  • An attempt to establish an in vitro-in vivo correlation: case of paracetamol immediate-release tablets.

    abstract::The purpose of this study was to investigate the possibility of developing different levels of in vitro-in vivo correlation for immediate-release paracetamol tablets using in vitro dissolution data obtained under various experimental conditions. The influence of agitation intensity and pH value of the dissolution medi...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03189824

    authors: Radovanović J,Durić Z,Jovanović M,Ibrić S,Petrović M

    更新日期:1998-01-01 00:00:00

  • A rapid determination of drug candidate tyrosol galactoside in rat plasma by HPLC and its application to the pharmacokinetics study.

    abstract::A simple and sensitive HPLC method has been developed and validated for the determination of tyrosol galactoside (TG) in rat plasma. After one-step protein precipitation with methanol, plasma samples were separated on an Ultimate AQ-C18 column (150 mm×4.6 mm, 5 μm) using acetonitrile-water (7:93, v/v) as mobile phase ...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/s13318-010-0015-8

    authors: Wang Q,Wang Y,Deng Y,Shi T,Liu X,Sun X,Li X,Zhou D

    更新日期:2011-01-01 00:00:00

  • The metabolism and excretion of 7-mono-0-(beta-hydroxyethyl) rutoside in the dog.

    abstract::Following i.v. administration of mono-HR to the beagle, plasma levels of both mono-HR and its glucuronide conjugates fell rapidly, neither being detectable 8 h after injection. Following oral administration of 14C-mono-HR, mono-HR-glucuronide was detected in plasma, confirming the absorption of mono-HR, and low levels...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03189428

    authors: Hackett AM,Griffiths LA

    更新日期:1979-01-01 00:00:00

  • Disposition of paclitaxel (Taxol) and its metabolites in patients with advanced breast cancer (ABC) when combined with trastuzumab (Hercpetin).

    abstract::Monoclonal antibodies are capable of modulating drug metabolising enzymes resulting in unexpected plasma concentrations of a drug when given concomitantly. Therefore plasma concentration of paclitaxel (PTX) and its metabolites has been monitored in 10 patients with advanced breast cancer during treatment with PTX alon...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03190613

    authors: Furtlehner A,Schueller J,Jarisch I,Ostermann E,Czejka M

    更新日期:2005-07-01 00:00:00

  • In vitro metabolism of galanthamine hydrobromide (Nivalin) by rat and rabbit liver homogenate.

    abstract::The metabolism of galanthamine hydrobromide (Nivalin) was investigated in rat and rabbit liver homogenates. Experiments were carried out varying several parameters of incubation: substrate (galanthamine hydrobromide, galanthamine, galanthaminone and epigalanthamine), cofactor enrichment (NADPH, NADP/G-6-P, NAD), pH (7...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03189858

    authors: Mihailova D,Velkov M,Zhivkova Z

    更新日期:1987-01-01 00:00:00

  • Changes in cyclosporine A kinetics after experimental reduction of renal parenchyma.

    abstract::Experimental chronic renal insufficiency (produced by 5/6 ablation of renal parenchyma) is associated with changes in the kinetics of oral (intragastric) cyclosporine A (CyA). Compared with animals with intact renal parenchyma, significantly lower levels of CyA are reached under these conditions. The factors responsib...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03189808

    authors: Schück O,Bohdanecká M,Sedivý J,Krajícková M,Chadimová M,Matousovic K

    更新日期:1997-07-01 00:00:00

  • Disposition of [3H]cloflumide, a new neuroleptic drug, in rats.

    abstract::The disposition of cloflumide (VUFB 15496), 2-chloro-7-fluoro-10 [4-(carbamoylethyl)piperazino]-10,11-dihydrodibenzo [b,f] thiepin methansulfonate, a new neuroleptic agent, following single oral and intravenous dose was studied in the rat using radiotracer techniques. [3H]Cloflumide was almost completely absorbed from...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03189883

    authors: Lapka R,Franc Z,Smolík S

    更新日期:1987-04-01 00:00:00

  • Study of the disposition kinetics of the N-oxide-derivative: a metabolite of picobenzide.

    abstract::The disposition kinetics of the N-oxide of picobenzide were studied after administration to rabbits at a bolus dose of 30 mg/kg of picobenzide intravenously. The biotransformation process fits a first-order kinetic process, and the metabolite shows good access capacity to the peripheral compartment. The N-oxide of pic...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章

    doi:10.1007/BF03190837

    authors: Santos Buelga D,Mariño EL,Domínguez-Gil A

    更新日期:1989-01-01 00:00:00

  • Pharmacogenetics of Cannabinoids.

    abstract::Although the application of medical marijuana and cannabinoid drugs is controversial, it is a part of modern-day medicine. The list of diseases in which cannabinoids are promoted as a treatment is constantly expanding. Cases of significant improvement in patients with a very poor prognosis of glioma or epilepsy have a...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章,评审

    doi:10.1007/s13318-017-0416-z

    authors: Hryhorowicz S,Walczak M,Zakerska-Banaszak O,Słomski R,Skrzypczak-Zielińska M

    更新日期:2018-02-01 00:00:00

  • Relative bioavailability and bioequivalence of metforphin hydrochloride extended-released and immediate-released tablets in healthy Chinese volunteers.

    abstract::The aim of the present study was to investigate the relative bioavailability and bioequivalence of a new tablet formulation of metformin hydrochloride with reference to a standard product in healthy Chinese adult male volunteers. Two randomized, comparative, two-way crossover studies were therefore conducted. In study...

    journal_title:European journal of drug metabolism and pharmacokinetics

    pub_type: 杂志文章,随机对照试验

    doi:10.1007/BF03190986

    authors: Li J,Jin Y,Wang TY,Lü XW,Li YH

    更新日期:2007-01-01 00:00:00